During the past decade, Mood & Anxiety Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mood & Anxiety Research" are "Depression" (1 trials), "Major Depressive Disorder" (1 trials) and "Sexual Dysfunctions, Psychological" (1 trials). Many other conditions were trialed in "Mood & Anxiety Research" in a lesser frequency.

Most popular intervention types in "Mood & Anxiety Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Agomelatine (AGO178C)" (1 trials), "Placebo" (1 trials), "flibanserin 100 mg qhs" (1 trials), "flibanserin 50 mg to 100 mg qhs" (1 trials) and "placebo 2 tablets qhs" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mood & Anxiety Research" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mood & Anxiety Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mood & Anxiety Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mood & Anxiety Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".